genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2024

Acute myeloid leukemia

Modeling Clonal Evolution in Hematopoietic Malignancies
Cancer

Modeling Clonal Evolution in Hematopoietic Malignancies

Overcoming Drug-Resistant Acute Myeloid Leukemia with Engineered Compound
Cancer

Overcoming Drug-Resistant Acute Myeloid Leukemia with Engineered Compound

NGS Panel for Acute Myeloid Leukemia
New Products

NGS Panel for Acute Myeloid Leukemia

Leukemia Relapse Could Be Prevented by Disrupting Immune Signaling Mechanism
Cancer

Leukemia Relapse Could Be Prevented by Disrupting Immune Signaling Mechanism

Exscientia Fires CEO for “Inappropriate” Relationships with Two Employees
Artificial Intelligence

Exscientia Fires CEO for “Inappropriate” Relationships with Two Employees

Pipeline Pruning: Exscientia Cuts Programs to Sharpen Precision Oncology Focus
Artificial Intelligence

Pipeline Pruning: Exscientia Cuts Programs to Sharpen Precision Oncology Focus

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar
GEN Edge

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar

Base Editing Tweaks HSC Epitopes for Targeted Immunotherapy
Cancer

Base Editing Tweaks HSC Epitopes for Targeted Immunotherapy

Stem Cells and Reprogramming in Human Acute Leukemia
Cancer

Stem Cells and Reprogramming in Human Acute Leukemia

Force of Nature: Caribou Biosciences Hits Clinical Runway with CRISPR-based Cancer Therapeutics
Cancer

Force of Nature: Caribou Biosciences Hits Clinical Runway with CRISPR-based Cancer Therapeutics

123...15Page 1 of 15

Read the Digital Edition

June 2024 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up